NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
NEJM Interviews · 2024-11-17
Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease. N Engl J Med. DOI: 10.1056/NEJMe2414477.
NEJM Interviews
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
- Número de episodios: 893
- Último episodio: 2025-06-25
- Salud y forma física
¿Donde puedes escuchar?
